5240 J . Org. Chem., Vol. 66, No. 15, 2001
Notes
4-(Meth ylth io)-5-(tr im eth ylsilyl)p en t-3-en yla m in e (7). A
2
h
at room temperature. A solution of aqueous KHCO3
100-mL flame-dried round-bottomed flask equipped with
a
(saturated, 2 mL) was added, and the biphasic mixture was
stirred vigorously for 1 h. The organic phase was removed and
the aqueous phase was extracted with CH2Cl2 (3 × 2 mL). The
combined organic phases were dried (MgSO4) and concentrated
in vacuo to give a deep yellow oil. The residue was subjected to
flash chromatography on silica gel (10% ethyl acetate/hexanes
for elution) to afford the title compound as a colorless, viscous
oil (52 mg, 76%). 1H NMR (300 MHz, CDCl3): δ 7.86 (d, 2H,
J ) 8.3 Hz, ArH), 6.83 (d, 2H, J ) 8.3 Hz, ArH), 4.54 (app s,
1H, -C(CH3S)dCHH), 4.12 (app s, 1H, -C(CH3S)dCHH), 3.99
(dd, 1H, J ) 4.9, 4.8 Hz, -CH2NCHCH-), 3.44 (m, 1H,
-NCHHCH2-), 3.15 (m, 1H, -NCHHCH2), 2.57 (m, 1H,
-CHCdCH2), 2.55 (m, 1H, -CH(CH3)3), 1.92 (s, 3H, ArCH3),
1.63 (s, 3H, SCH3), 1.52 (m, 1H, -NCHCHH), 1.41 (m, 1H,
-NCHCHH), 1.04 (d, 3H, J ) 7.0 Hz, -CH(CH3)2), 0.95 (d, 3H,
J ) 6.9 Hz, -CH(CH3)2). 13C NMR (75 MHz, CDCl3): δ 149.8,
143.4, 137.8, 129.6, 103.2, 69.9, 49.5, 47.8, 33.7, 32.5, 21.2, 19.7,
17.03, 14.3. IR (film): 2972, 2915, 2867, 1593, 1464, 1339, 1152,
1089, 1046, 998, 840 cm-1. HRMS (EI): 339.1329 m/z (calcd for
Teflon-coated magnetic stirring bar, reflux condenser, and a
rubber septum was charged with N-[(4-methylthio)-5-(trimeth-
ylsilyl)pent-3-enyl]pthalimide (6) (1.5 g, 4.5 mmol) and ethanol
(50 mL). The reaction mixture was treated with hydrazine
monohydrate (0.48 g, 9.50 mmol) and heated to reflux temper-
atures with stirring for 8 h. The heterogeneous mixture was
cooled to ambient temperature and filtered through a pad of
Celite. The filtrate was concentrated, and the residue was
triturated with pentane, filtered through a pad of Celite, and
concentrated. The residue was purified by bulb-to-bulb distilla-
tion (120 °C at 0.25 Torr) to afford the title compound as a
colorless liquid (0.84 g, 92%), which consisted of 2 inseparable
isomers (7:1 E/Z isomeric ratio) (major isomer only). 1H NMR
(300 MHz, CDCl3): δ 4.86 (app t, 1H, J ) 7.2 Hz, -CH2CHd),
2.68 (t, 2H, J ) 7.0 Hz, H2NCH2CH2-), 2.17 (s, 3H, -SCH3),
2.16 (m, 2H, H2NCH2CH2CHd), 1.75 (s, 2H, -CH2Si(CH3)3), 1.28
(bs, 2H, -NH2), 0.05 (s, 9H, -CH2Si(CH3)3). 13C NMR (75 MHz,
CDCl3): δ 135.9, 115.2, 42.7 34.31, 23.6, 15.5, 0.48. IR (film):
3370, 3299, 2952, 2919, 1618, 1438, 1424, 1247, 1156, 958, 856,
C
17H25NO2S2, 339.1327), ppm error ) -0.7.
724 cm-1. HRMS (EI+) (M + 1) 204.1232 m/z (calcd for C9H22
NSSi, 204.1242), ppm error ) 5.1.
-
P yr r olizid in on e (10). A 25-mL flame-dried round-bottomed
flask containing a Teflon-coated magnetic stirring bar and a
rubber septum was charged with 4-(methylthio)-5-(trimethylsi-
lyl)pent-3-enylamine (7) (203 mg, 1.00 mmol), 4 Å molecular
sieves, and CH2Cl2 (2 mL). Ethyl levulinate (144 mg, 1.00 mmol)
was added to the reaction mixture and stirred for 12 h at
ambient temperature. The reaction mixture was diluted with
hexane and filtered through a plug of Celite. The filtrate was
concentrated, and the residue was dissolved in CH2Cl2 (10 mL).
This solution was cooled to -78 °C and treated dropwise over a
2-min period with TiCl4 (1.50 mL of mL 0.70 M in toluene, 1.00
mmol) via syringe. The resulting deep orange solution was
stirred for 3 h at -78 °C followed by an additional 12 h at -20
°C. The reaction mixture was transferred dropwise via cannula
into a vigorously stirred, saturated aqueous solution of KHCO3
cooled to 0 °C. The biphasic mixture was stirred for 30 min at
ambient temperature. The organic phase was removed, and the
aqueous phase was extracted with CH2Cl2 (2 × 5 mL). The
combined organic phases were then dried with Na2SO4, filtered,
and concentrated to give a thick oil, which was subjected to flash
chromatography (20% ethyl acetate/hexane followed by 90%
ethyl acetate/hexane for elution) to give the title compound as a
colorless oil (175 mg, 83%). 1H NMR (300 MHz, C6D6): δ 4.76
(app s, 1H, -C(CH3S)dCHH), 4.44 (app s, 1H, -C(CH3S)dCHH),
3.88 (app dt, 1H, J ) 6.8, 7.4 Hz, -NCHHCH2), 2.76 (ddd, 1H,
J ) 1.0, 7.4, 11.3 Hz, -NCHHCH2-), 2.46 (m, 1H, OdCCHH-),
2.32 (app t, 1H, J ) 6.6 Hz, dCCH-), 2.30 (m, 1H, OdCCH2-
CHH-), 2.05 (app dt, 1H, J ) 9.9, 12.8 Hz, OdCCHH-), 1.85
(m, 1H, OdCCH2CHH), 1.81 (m, 1H -NCH2CHH-), 1.79 (s, 3H,
-SCH3), 1.44 (ddd, 1H, J ) 2.5, 9.3, 15.3 Hz, OdCH2CHH), 1.04
(s, 3H, -CCH3). 13C NMR (75 MHz, C6D6): δ 173.9, 148.19,
103.7, 69.2, 53.8, 40.3, 33.3, 31.9, 28.9, 27.8, 14.1. IR (film): 2967,
2918, 1692, 1392, 1244, 842 cm-1. HRMS (EI+): 211.1027 (calcd
for C11H17NOS, 211.1031), ppm error ) 1.7.
N-(2-Meth ylp r op ylid en e)-4-m eth ylth io-5-tr im eth ylsilyl-
3-p en ten -1-a m in e (1a ). The following serves as a general
experimental procedure used for the preparation of aldimines.
A 10-mL single-necked, round-bottomed flask equipped with a
Teflon-coated magnetic stirring bar and a rubber septum was
charged with activated 4 Å molecular sieves (700 mg), 4-(meth-
ylthio)-5-(trimethylsilyl)pent-3-enylamine (7) (0.203 g, 1.00 mmol),
and CH2Cl2 (2 mL). Freshly distilled isobutyraldehyde (0.087 g,
1.20 mmol) was added to the reaction mixture and stirred for
12 h at ambient temperature. The reaction mixture was diluted
with hexane (∼5 mL) and filtered through
a Celite pad.
Evaporation of the solvent and excess aldehyde in vacuo afforded
the title aldimine (0.252 g, 98%) as a colorless oil, which was
used immediately in the next step (2a (Ts)). Crude aldimines (1a -
g, and the ketimine precursor for 10) were prepared using this
procedure.
Tr a n s-N-tosyl-2-isop r op yl-3-[(2-m eth ylth io)eth en yl]p yr -
r olid in e (2a (Ts)). The following represents the general experi-
mental procedure used for the preparation of pyrrolidines from
the corresponding aldimines. A 5-mL flame-dried round-bot-
tomed flask containing a Teflon-coated magnetic stirring bar and
a rubber septum was charged with a solution of freshly prepared
aldimine 1a (52 mg, 0.20 mmol) in CH2Cl2 (2 mL). The solution
was cooled to -78 °C and treated dropwise over a 2 min period
with TiCl4 (0.32 M in toluene, 0.63 mL, 0.20 mmol). The resulting
deep orange solution was stirred for 3 h at -78 °C followed by
an additional 12 h at -20 °C. The reaction mixture was
transferred dropwise via cannula into a vigorously stirred,
saturated aqueous solution of KHCO3 cooled to 0 °C. The
biphasic mixture was stirred for 30 min at ambient temperature
and decanted into a separatory funnel. The organic phase was
removed, and the aqueous phase was extracted with CH2Cl2
(2 × 5 mL). The combined organic phases were then dried with
MgSO4, filtered, and concentrated to give a thick yellow oil. For
the purposes of complete and accurate characterization as well
as NOE analysis, the pyrrolidine was immediately converted to
the corresponding N-tosylate via the following procedure. A 25-
mL flame-dried round-bottomed flask containing a Teflon-coated
magnetic stirring bar and a rubber septum was charged with
the crude pyrrolidine (0.20 mmol calc), pyridine (0.65 µL, 0.80
mmol), and CH2Cl2 (2 mL). The reaction mixture was cooled to
0 °C, and TsCl (38 mg, 0.20 mmol) was added in one portion.
The mixture was stirred at 0 °C for 2 h followed by an additional
Ack n ow led gm en t. Generous financial support for
this research by a grant from the National Institutes of
Health is gratefully acknowledged.
Su p p or tin g In for m a tion Ava ila ble: Experimental pro-
cedures and listings of 1H and 13C NMR, IR, and HRMS
composition data for all new compounds. This material is
J O0015366